SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-19-000166
Filing Date
2019-05-21
Accepted
2019-05-21 17:12:33
Documents
52
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 471976
2 302 CERTIFICATE exh31-1.htm EX-31.1 7471
3 906 CERTIFICATE exh32-1.htm EX-32.1 2587
  Complete submission text file 0001136261-19-000166.txt   3004483

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT seel-20190331.xml EX-101.INS 306400
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT seel-20190331.xsd EX-101.SCH 55611
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT seel-20190331_cal.xml EX-101.CAL 66010
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT seel-20190331_def.xml EX-101.DEF 263067
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT seel-20190331_lab.xml EX-101.LAB 410498
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT seel-20190331_pre.xml EX-101.PRE 397574
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 19843216
SIC: 2834 Pharmaceutical Preparations